News - Ghost Supply

25 May

May 22, 2026 -- A team of researchers at the National Institutes of Health (NIH) have unveiled new details about the events GLP-1 recep...

25 May

Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One...

25 May

Bepirovirsen Accepted for Priority Review and Granted Breakthrough Therapy Designation by the US FDA London, UK -- 28 April 2026 GSK p...

25 May

U.S. Food and Drug Administration Accepts New Drug Application for Zipalertinib for the Treatment of Locally Advanced or Metastatic Non...